Lb Pharmaceuticals Inc.
Clinical trials sponsored by Lb Pharmaceuticals Inc., explained in plain language.
-
New schizophrenia drug shows promise in large trial
Symptom relief Recruiting nowThis study tests a new medication, LB 102, to see if it can reduce symptoms of schizophrenia in adults experiencing a sudden worsening of their condition. About 456 participants will receive either LB 102 or a placebo for 6 weeks. The goal is to measure changes in symptom severit…
Phase: PHASE3 • Sponsor: LB Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 17, 2026 09:07 UTC
-
New drug aims to lift depression in bipolar i patients
Symptom relief Recruiting nowThis study tests an experimental drug called LB-102 to see if it can safely reduce depression symptoms in adults with Bipolar I Disorder who are currently having a major depressive episode. About 320 participants will be randomly assigned to receive either LB-102 or a placebo for…
Phase: PHASE2 • Sponsor: LB Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC